SynthesisPloS one2022

Predictive value of tumor mutational burden for immunotherapy in non-small cell lung cancer: A systematic review and meta-analysis.

Guangxian Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.